A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects
Status:
Unknown status
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
This study is a Phase I, Randomised, Double-Blind, Placebo-Controlled, Dose-Escalation Study
to Evaluate Safety, Tolerability and Pharmacokinetics After Single and Multiple Oral
Administration of DA-8010 in Healthy Subjects.